Samuel C.
About Samuel C.
Samuel C. is the Director of Research & Development at Precision NanoSystems Inc., where he specializes in nucleic acid drug delivery and lipid nanoparticles. He holds a Ph.D. and has extensive experience in RNA technologies, having previously worked at STEMCELL Technologies and Ecole Normale Supérieure.
Work at Precision NanoSystems
Samuel C. serves as the Director of Research & Development at Precision NanoSystems Inc. since 2017. In this role, he focuses on advancing RNA technologies and nucleic acid drug delivery systems. His work involves the development of innovative solutions for genetic vaccines and gene and cell therapies. Samuel's leadership in research initiatives contributes to the company's mission of enhancing therapeutic delivery methods.
Education and Expertise
Samuel C. holds a Bachelor’s degree from the University of Victoria, where he studied from 2001 to 2004. He furthered his education at McGill University, earning a Ph.D. from 2005 to 2008. His academic background laid the foundation for his expertise in RNA technologies, nucleic acid drug delivery, and lipid nanoparticles, which are critical in the field of genetic therapies.
Background
Before joining Precision NanoSystems, Samuel C. worked at STEMCELL Technologies as Associate Director of Cell Separation & Nanoparticle Chemistry from 2010 to 2017. He also served as a Postdoctoral Research Fellow at Ecole Normale Supérieure in Paris from 2008 to 2010. His diverse experiences in research and development have shaped his approach to advancing therapeutic technologies.
Achievements
Samuel C. has made significant contributions to the field of gene therapy, particularly in the development of mRNA gene therapy. He has presented a webinar on non-viral gene therapy, sharing insights and advancements in this area. His work is recognized for its impact on the development of genetic vaccines and therapeutic delivery systems.